# BeOne Medicines clinical trials: 69 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 69 trials with BeOne Medicines as lead sponsor, 49 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by BeOne Medicines: 69 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 4 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/beone-medicines

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 69
- Recruiting or not yet: 49
- Read on: November 19, 2026

## Trials

The 25 newest of 69, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 12, 2026 | NCT07934069 | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect of BON-107 in Healthy Participants | BeOne Medicines | Phase 1 | Not yet recruiting | Healthy Participants | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07934069) |
| November 3, 2026 | NCT07911683 | Study Evaluating the Efficacy and Safety of BGB-B2033 in Participants With Advanced Hepatocellular Carcinoma | BeOne Medicines | Phase 2 | Not yet recruiting | Hepatocellular Cancer, Liver Cancer, Hepatocellular Carcinoma | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07911683) |
| October 29, 2026 | NCT07904845 | A Study of BON-C1393 in Adults With Advanced Solid Tumors | BeOne Medicines | Phase 1 | Not yet recruiting | Solid Tumors, Advanced Solid Tumors | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07904845) |
| October 27, 2026 | NCT07896460 | A First-in-Human Study of BG-92505 Alone or in Combination With Other Anti-cancer Agents in Patients With Advanced Solid Tumors | BeOne Medicines | Phase 1 | Not yet recruiting | Advanced Solid Tumor | 137 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07896460) |
| October 26, 2026 | NCT07893535 | An Investigational Study of BON-106 in Adults With Advanced or Metastatic Solid Tumors | BeOne Medicines | Phase 1 | Not yet recruiting | Solid Tumor, Advanced Solid Tumor, Metastatic Solid Tumor | 96 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07893535) |
| October 21, 2026 | NCT07887646 | A Study Investigating the Safety and How the Trispecific T-Cell Engaging Antibody BG-T0920 Works in Adults With Diffuse Large B-cell... | BeOne Medicines | Phase 1 | Not yet recruiting | Diffuse Large B-Cell Lymphoma, B-cell Malignancies | 70 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07887646) |
| October 19, 2026 | NCT07881211 | A Study Investigating the Safety and How the Trispecific T-Cell Engaging Antibody BG-T0050 Works in Adults With Diffuse Large B-cell... | BeOne Medicines | Phase 1 | Not yet recruiting | Diffuse Large B-Cell Lymphoma, B-Cell Malignancies | 70 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07881211) |
| October 2, 2026 | NCT07856004 | A Study to Investigate Safety, Tolerability, and Pharmacokinetics of Tacabrutideg (BGB-16673) in Participants With Moderate and Severe... | BeOne Medicines | Phase 1 | Not yet recruiting | Hepatic Impairment, Healthy Adult Participants | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07856004) |
| October 2, 2026 | NCT07855991 | A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Sonrotoclax in Participants With Severe Hepatic Impairment | BeOne Medicines | Phase 1 | Not yet recruiting | Hepatic Impairment, Healthy Adult Participants | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07855991) |
| September 23, 2026 | NCT07836530 | Study Comparing BGB-B2033 With Sorafenib or Lenvatinib in Advanced Hepatocellular Carcinoma | BeOne Medicines | Phase 3 | Recruiting | Hepatocellular Carcinoma, Liver Cancer | 492 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07836530) |
| September 15, 2026 | NCT07820891 | A Trial in Healthy Participants to Assess Drug Interaction Potential of BGB-43395 | BeOne Medicines | Phase 1 | Recruiting | Healthy Adult Participants | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07820891) |
| September 10, 2026 | NCT07811271 | Efficacy and Safety of BG-C9074 With Bevacizumab Compared With Bevacizumab in Adults With Ovarian, Fallopian Tube, or Primary Peritoneal... | BeOne Medicines | Phase 3 | Not yet recruiting | Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer | 600 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07811271) |
| August 18, 2026 | NCT07770698 | A Study of Sonrotoclax (BGB-11417) in Children With Relapsed or Refractory Acute Myeloid Leukemia and B-cell Acute Lymphoblastic Leukemia | BeOne Medicines | Phase 1/2 | Not yet recruiting | Relapsed Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia, B-cell Acute Lymphoblastic Leukemia, Pediatric... | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07770698) |
| August 4, 2026 | NCT07746141 | A First-in-Human Study Investigating BG-85738 Alone or in Combination With Other Antitumor Agents in Patients With Advanced or Metastatic... | BeOne Medicines | Phase 1 | Recruiting | RAS Mutation, Advanced Solid Tumor, Metastatic Solid Tumor | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07746141) |
| July 29, 2026 | NCT07733180 | A Study Investigating Alternate Schedules of Tislelizumab Plus Chemotherapy in Japanese Patients With First-line Advanced ESCC | BeOne Medicines | Phase 2 | Recruiting | Advanced Esophageal Squamous Cell Carcinoma, Metastatic Esophageal Squamous Cell Carcinoma | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07733180) |
| July 17, 2026 | NCT07712640 | A Study to Investigate the Relative Bioavailability of 2 Tablet Formulations and the Effect of Food on the Pharmacokinetics of BGB-58067 in... | BeOne Medicines | Phase 1 | Recruiting | Healthy Volunteers | 32 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07712640) |
| June 17, 2026 | NCT07652736 | A Study to Investigate Treatment Patterns and Effectiveness of Tislelizumab in European Patients With Resectable or Advanced Non-Small Cell... | BeOne Medicines | Observational | Recruiting | Advanced Non-Small Cell Lung Cancer, Extensive-Stage Small Cell Lung Cancer | 440 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07652736) |
| June 5, 2026 | NCT07628881 | A Study to Investigate the Relative Bioavailability and Food Effect of Tablet for Oral Suspension of Sonrotoclax in Healthy Adults | BeOne Medicines | Phase 1 | Completed | Healthy Volunteers | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07628881) |
| June 1, 2026 | NCT07619287 | An Investigational Study of BG-75202 Alone and in Combination With Other Agents in Patients With Myeloid Malignancies | BeOne Medicines | Phase 1 | Recruiting | Myeloid Malignancy | 118 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07619287) |
| May 15, 2026 | NCT07590102 | A Study to Investigate the Effect of the CYP3A Inducer Phenytoin and the CYP3A Inhibitor Itraconazole on the Pharmacokinetics of BGB-58067... | BeOne Medicines | Phase 1 | Recruiting | Healthy Volunteers | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07590102) |
| April 28, 2026 | NCT07554521 | A Study to Evaluate Efficacy and Safety of Tislelizumab Plus Chemotherapy for Locally Advanced Unresectable or Metastatic Gastric or... | BeOne Medicines | Phase 2 | Recruiting | Advanced Unresectable Gastric Adenocarcinoma, Esophageal Squamous Cell Carcinoma, Advanced Gastroesophageal... | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07554521) |
| March 25, 2026 | NCT07492641 | BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not... | BeOne Medicines | Phase 3 | Recruiting | HR+/HER2- Breast Cancer | 1,056 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07492641) |
| February 17, 2026 | NCT07414836 | A First-in-Human Study of BG-C0979 in Adults With Advanced Solid Tumors | BeOne Medicines | Phase 1 | Recruiting | Advanced Solid Tumor | 84 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07414836) |
| February 17, 2026 | NCT07412691 | A Study to Evaluate the Safety of BG-A3004 in Healthy Participants and Patients With Immune-Mediated Skin Diseases | BeOne Medicines | Phase 1 | Recruiting | Skin Diseases | 98 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07412691) |
| December 11, 2025 | NCT07277231 | A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With... | BeOne Medicines | Phase 3 | Recruiting | Chronic Lymphocytic Leukemia | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07277231) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 38 |
| Phase 1/2 | 9 |
| Phase 2 | 5 |
| Phase 2/3 | 1 |
| Phase 3 | 15 |
| Observational | 1 |

## By status

| Status | Trials |
| --- | --- |
| Recruiting | 38 |
| Not yet recruiting | 11 |
| Active not recruiting | 10 |
| Completed | 5 |
| Terminated | 5 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Leukemia, Lymphocytic, Chronic, B-Cell | 11 |
| Lymphoma, Mantle-Cell | 6 |
| Neoplasm Metastasis | 4 |
| Breast Neoplasms | 4 |
| Lymphoma, Large B-Cell, Diffuse | 4 |
| Lymphoma, Non-Hodgkin | 4 |
| Lymphoma, Follicular | 4 |
| Lymphoma, B-Cell, Marginal Zone | 4 |
| Carcinoma, Hepatocellular | 3 |
| Waldenstrom Macroglobulinemia | 3 |
| Liver Neoplasms | 2 |
| Esophageal Squamous Cell Carcinoma | 2 |
| Recurrence | 2 |
| Neoplasms | 2 |
| Lymphoma, B-Cell | 2 |
| Leukemia, Myeloid, Acute | 2 |
| Lymphoma | 2 |
| Small Cell Lung Carcinoma | 1 |
| Multiple Myeloma | 1 |
| Myelodysplastic Syndromes | 1 |
| Myelodysplastic-Myeloproliferative Diseases | 1 |
| Simpson-Golabi-Behmel syndrome | 1 |
| Chronic Urticaria | 1 |
| Carcinoma, Ovarian Epithelial | 1 |
| Fallopian Tube Neoplasms | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Fabric wholesalers in the United States](https://specstream.ai/data/businesses/fabric-wholesalers/united-states)
- [IT companies in the United States](https://specstream.ai/data/businesses/it-companies/united-states)
- [Pediatric gastroenterology practices in the United States](https://specstream.ai/data/businesses/pediatric-gastroenterology-practices/united-states)
- [Sports medicine clinics in the United States](https://specstream.ai/data/businesses/sports-medicine-clinics/united-states)
- [American restaurants in the United States](https://specstream.ai/data/businesses/american-restaurants/united-states)
- [Certification bodies in the United States](https://specstream.ai/data/businesses/certification-bodies/united-states)
